Subscribe to Search results

In a memo from Dr Isaacs to Dr Rotblat, Dr Isaacs attached a letter received from Peter Jones in which he suggested taking action against the Armour material.

Published on:

An editorial in the "British Medical Journal" asserted that the protein fractionation centres lacked sufficient staff, accommodation, equipment and the basic organisational units to do the job.

Published on:

In a letter from Dr Biggs to Dr Godber, she called attention to the lack of organisation, apparatus and buildings needed in order to produce Factor 8.

Published on:

In the minutes of an AIDS group of haemophilia centre directors' meeting, Dr Mortimer told the meeting that he was concerned to see that a large number of centres were still using non-heat-treated Factor 8, and suggested that all directors should be advised not to use it.

Published on:

During a meeting of the AIDS group of haemophilia centre directors, directors were recommended to use only heat-treated products now these were available.

Published on:

At a UKHCDO Hepatitis Working Party meeting Dr Craske identified eight patients treated with (unheated) Factor 9 who had seroconverted.

Published on:

Haemofact No 6 reported that Lord Glenarthur, Parliamentary Under-Secretary of State for Health, speaking in the House of Lords, had made it clear that all home produced Factor 8 would be heat treated from April 1985.

Published on:

The "Daily Mail" published a front page article with the headline "AIDS Virus kills man in Britain".

Published on:

The "Daily Express" published an article titled "Twin bid to curb killer AIDS peril".

Published on:

"The Times" published an article titled "Treated blood cuts Aids risk to haemophiliacs".

Published on:

Douglas Starr, in his book "An Epic History of Medicine and Commerce" commented: "Once AIDS became an acknowledged reality, the drug firms quickly developed screening tests and virus-killing technologies...If they had heeded the warnings of Factor VIII...they would have abandoned the high-risk collection centres sooner and worked more intensively on virus-killing technology."

Published on:

Professor Titmuss published his book "The Gift Relationship".

Published on:

The use of genetically engineered blood clotting agents was announced in October 1988 at the Royal Free Hospital.

Published on:

At a Haemophilia Society Executive Committee meeting it was reported that "the introduction of heat-treated materials has been 'patchy' and that at least one Supra-Region had not yet introduced heat-treated materials."

Published on:

Dr Denis Donohue of the FDA asked the pharmaceutical companies to stop using blood collected from donors likely to have high levels of antibodies to hepatitis.

Published on:

By this time, self-sufficiency had largely been achieved.

Published on:

Professor Edward Tuddenham told the Inquiry that inactivation could and should have been achieved earlier.

Published on:

Christopher Bishop asserted in his oral evidence that Armour had done: "everything possible to provide the best possible treatment and the most up-to-date systems in accordance with the state of art at that time."

Published on:

Dr Peter Foster stated in his oral evidence to the Inquiry that it was difficult dealing with a possible virus, the structure of which was unknown. However, both BPL and PFC managed to inactivate NANBH before the structure of Hepatitis C was known.

Published on:

Experiments were conducted by Dr Shohachi Wada on behalf of Cutter to see if the hepatitis virus with which Factor 9 was spiked could be inactivated whilst the Fator 9 was kept active.

Published on: